Seven-Day Continuous Abstinence Rate from Smoking at 1, 2, or 3 Years after the Use of Varenicline

BACKGROUND: Varenicline, a selective partial agonist/antagonist of the α4β2 nicotinic receptor, has proven effectiveness for smoking cessation by several randomized, controlled trials. Because few studies have evaluated the long-term efficacy of varenicline, we tried to evaluate the smoking status o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Se, Jang, Ju Young, Park, Eun Hye, Lee, Joo Young, Gu, Kang Mo, Jung, Jae Woo, Choi, Jae Chol, Shin, Jong Wook, Park, In Won, Choi, Byoung Whui, Kim, Jae Yeol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388906/
https://www.ncbi.nlm.nih.gov/pubmed/25861342
http://dx.doi.org/10.4046/trd.2015.78.2.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388906/
https://www.ncbi.nlm.nih.gov/pubmed/25861342
http://dx.doi.org/10.4046/trd.2015.78.2.92

Ejemplares similares